Sundaram Multi Pap
NSE: SUNDARAMBSE: 533166
₹ 1.04▼ 0.01 (−0.95%)28 Oct, 03:28 pm IST
- Market cap
- ₹ 50 Cr.
- P/E
- 57.1x
- P/B
- 0.55x
- 52-week range
- 0.99 – 2.1
- ROE
- 3%
- ROCE
- 4%
- Dividend yield
- 0%
- Debt / equity
- 0.23
- Sector
- Household Products
- Industry
- Stationary
- Listed on
- NSE, BSE
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Stationary: 9 companies →Sundaram Multi Pap against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)57.1 against a typical 22.3: pricier than most peers (1st = cheapest).9th of 9
- Sales growth+22% against a typical +0.9% from a year earlier.1st of 8
- Share price, 3 months−18.7% against a typical −12.9%.6th of 8
- Size₹ 50.1 Cr. market value against a typical ₹ 548.1 Cr. (1st = largest).6th of 7
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | Withdrawn | — | 22 Aug 2025 |
Every agency has withdrawn its rating.
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 22 Aug 2025 | Withdrawn | — | — | CRISIL | ₹ 40 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 13 Aug 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters |
| 25 May 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2026 and other business matters |
| 5 Mar 2026 | Other business matters | To consider other business matters |
| 14 Feb 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2025 and other business matters |
| 13 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
| 16 Oct 2025 | Other business matters | To consider other business matters |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 22 | 22 | 41 | 42 | 24 | 21 | 40 | 41 | 26 | 26 | 44 | 50 |
| Expenses | 23 | 22 | 38 | 39 | 24 | 22 | 41 | 40 | 24 | 24 | 43 | 48 |
| Operating Profit | −0 | −0 | 3 | 4 | −0 | −1 | −1 | 1 | 2 | 2 | 1 | 1 |
| OPM % | −1.1% | −2.1% | 6.4% | 8.8% | −0.2% | −4.2% | −2.9% | 2.8% | 6.7% | 8.1% | 2% | 2.3% |
| Other Income | −0 | 0 | −0 | −2 | −0 | 0 | 2 | 0 | 0 | 1 | 1 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | −0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | −2 | −2 | 0 | 0 | −2 | −3 | −1 | −0 | 1 | 2 | 1 | 0 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | −2 | −2 | 0 | 0 | −2 | −3 | −1 | −0 | 1 | 2 | 1 | 0 |
| EPS in Rs | −0.05 | −0.05 | 0.01 | 0.01 | −0.04 | −0.06 | −0.02 | −0.01 | 0.02 | 0.03 | 0.02 | 0.01 |
Growth and returns
Compounded yearly rates over each period.
Compounded Sales Growth
- 10 Years
- 4%
- 5 Years
- 22%
- 3 Years
- 6%
- TTM
- 16%
Compounded Profit Growth
- 10 Years
- 19%
- 5 Years
- 18%
- 3 Years
- −21%
- TTM
- 159%
Stock Price CAGR
- 10 Years
- −12%
- 5 Years
- −9%
- 3 Years
- −17%
- TTM
- —
Return on Equity
- 10 Years
- 1%
- 5 Years
- 1%
- 3 Years
- −2%
- TTM
- —
Prices are delayed and for information only. Nothing on this page is investment advice.